CN102907416A - 一种可维持细胞活性的组织冻存液 - Google Patents
一种可维持细胞活性的组织冻存液 Download PDFInfo
- Publication number
- CN102907416A CN102907416A CN2012102721142A CN201210272114A CN102907416A CN 102907416 A CN102907416 A CN 102907416A CN 2012102721142 A CN2012102721142 A CN 2012102721142A CN 201210272114 A CN201210272114 A CN 201210272114A CN 102907416 A CN102907416 A CN 102907416A
- Authority
- CN
- China
- Prior art keywords
- adipose tissue
- cell
- tissue
- cryopreserving liquid
- ksr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 68
- 238000005138 cryopreservation Methods 0.000 title claims abstract description 13
- 230000000694 effects Effects 0.000 title abstract description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 116
- 210000004027 cell Anatomy 0.000 claims abstract description 102
- 210000000130 stem cell Anatomy 0.000 claims abstract description 46
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 33
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 33
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 33
- 210000002966 serum Anatomy 0.000 claims abstract description 11
- 210000000577 adipose tissue Anatomy 0.000 claims description 83
- 210000001519 tissue Anatomy 0.000 claims description 49
- 239000000203 mixture Substances 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 28
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 16
- 238000004321 preservation Methods 0.000 claims description 15
- 238000001816 cooling Methods 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 230000009467 reduction Effects 0.000 claims description 7
- 230000012010 growth Effects 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000004069 differentiation Effects 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 24
- 238000011084 recovery Methods 0.000 description 22
- 238000007710 freezing Methods 0.000 description 16
- 230000008014 freezing Effects 0.000 description 15
- 230000006378 damage Effects 0.000 description 13
- 230000001464 adherent effect Effects 0.000 description 12
- 102000036639 antigens Human genes 0.000 description 10
- 108091007433 antigens Proteins 0.000 description 10
- 230000010261 cell growth Effects 0.000 description 10
- 239000000427 antigen Substances 0.000 description 9
- 239000013078 crystal Substances 0.000 description 8
- 230000035699 permeability Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 102100022464 5'-nucleotidase Human genes 0.000 description 6
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 6
- 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 description 6
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 6
- 102100032818 Integrin alpha-4 Human genes 0.000 description 6
- 102100025304 Integrin beta-1 Human genes 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 5
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 5
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 5
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 5
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 5
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 4
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000009194 climbing Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 102000007469 Actins Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 102000006354 HLA-DR Antigens Human genes 0.000 description 3
- 108010058597 HLA-DR Antigens Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 101710160107 Outer membrane protein A Proteins 0.000 description 3
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 3
- 210000003995 blood forming stem cell Anatomy 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 102000013925 CD34 antigen Human genes 0.000 description 2
- 108050003733 CD34 antigen Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 239000002458 cell surface marker Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
- 102100037241 Endoglin Human genes 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 108010013709 Leukocyte Common Antigens Proteins 0.000 description 1
- 102000017095 Leukocyte Common Antigens Human genes 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000030944 contact inhibition Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003237 epithelioid cell Anatomy 0.000 description 1
- ODLMAHJVESYWTB-UHFFFAOYSA-N ethylmethylbenzene Natural products CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000002637 fluid replacement therapy Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000024278 histolysis Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000001002 morphogenetic effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 238000004017 vitrification Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Images
Abstract
Description
组序 | A组 | B组 |
P3代细胞量 | 2.43×108 | 2.1×108 |
抗体 | CD29 | CD73 | CD49d | CD90 | CD14 | CD45 | CD34 | Actin | HLA-DR |
A组 | 99.4% | 99.7% | 99.8% | 99.0% | 0.1% | 0.1% | 0.6% | 0.2% | 0.1% |
B组 | 99.8% | 99.3% | 99.3% | 99.2% | 1.2% | 0.1% | 1.3% | 0.5% | 0.1% |
组序 | C组 | D组 |
SVF细胞量 | 1.2×107 | 4.1×106 |
SVF细胞活率 | 80% | 65% |
P3代细胞量 | 2.1×108 | 5×107 |
组别 | SVF细胞量 | P3代细胞量 |
1 | 7×106 | 1.3×108 |
2 | 9×106 | 1.7×108 |
3 | 1×107 | 2×108 |
4 | 8×106 | 1.5×108 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210272114.2A CN102907416B (zh) | 2012-08-01 | 2012-08-01 | 一种可维持细胞活性的组织冻存液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210272114.2A CN102907416B (zh) | 2012-08-01 | 2012-08-01 | 一种可维持细胞活性的组织冻存液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102907416A true CN102907416A (zh) | 2013-02-06 |
CN102907416B CN102907416B (zh) | 2016-08-03 |
Family
ID=47606181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210272114.2A Active CN102907416B (zh) | 2012-08-01 | 2012-08-01 | 一种可维持细胞活性的组织冻存液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102907416B (zh) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105494317A (zh) * | 2016-03-06 | 2016-04-20 | 李倩 | 一种人脂肪干细胞用的细胞冻存液 |
CN106719602A (zh) * | 2016-11-30 | 2017-05-31 | 广州赛莱拉干细胞科技股份有限公司 | 一种冻存液及其应用与冻存脂肪组织的方法 |
CN106719600A (zh) * | 2016-11-30 | 2017-05-31 | 广州赛莱拉干细胞科技股份有限公司 | 一种脂肪组织冻存液 |
CN108048398A (zh) * | 2017-12-23 | 2018-05-18 | 淮北智淮科技有限公司 | 一种干细胞冻存与复苏方法 |
RU2655222C2 (ru) * | 2016-05-05 | 2018-05-24 | Константин Валентинович Котенко | Способ подготовки жировой ткани к криоконсервированию |
CN108552156A (zh) * | 2017-11-13 | 2018-09-21 | 广东艾时代生物科技有限责任公司 | 一种无血清的诱导多功能干细胞冻存液及冻存方法 |
WO2018214943A1 (zh) * | 2017-05-24 | 2018-11-29 | 西比曼生物科技(上海)有限公司 | 一种冻存细胞制剂及细胞复苏方式 |
CN109221089A (zh) * | 2018-10-16 | 2019-01-18 | 浙江美泰生物科技有限公司 | 一种脂肪组织的冻存液及脂肪组织冻存的方法 |
CN109380214A (zh) * | 2018-12-28 | 2019-02-26 | 中国医学科学院整形外科医院 | 一种无血清细胞冻存剂及其制备方法、使用方法,冻存液 |
CN109430252A (zh) * | 2018-12-25 | 2019-03-08 | 成都赋智健康科技有限公司 | 一种干细胞冻存液及其制作方法 |
CN109497043A (zh) * | 2018-12-28 | 2019-03-22 | 中国医学科学院整形外科医院 | 无血清纳米材料冻存剂及其制备方法、使用方法,冻存液 |
CN109566600A (zh) * | 2018-12-29 | 2019-04-05 | 中国医学科学院整形外科医院 | 一种用于脂肪干细胞的冻存前处理方法 |
CN109845728A (zh) * | 2019-03-25 | 2019-06-07 | 西安医斯美生物科技有限公司 | 临床应用级别的脂肪组织冻存液及冻存方法 |
CN110839616A (zh) * | 2019-11-29 | 2020-02-28 | 安徽惠恩生物科技股份有限公司 | 一种干细胞的冷冻液及其冷冻方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003024215A1 (en) * | 2001-09-14 | 2003-03-27 | Macropore Biosurgery, Inc. | Preservation of non embryonic cells from non hematopoietic tissues |
CN102550542A (zh) * | 2011-08-09 | 2012-07-11 | 臻景生物技术(上海)有限公司 | 用于脂肪干细胞的无血清冻存液及脂肪干细胞库的建立 |
-
2012
- 2012-08-01 CN CN201210272114.2A patent/CN102907416B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003024215A1 (en) * | 2001-09-14 | 2003-03-27 | Macropore Biosurgery, Inc. | Preservation of non embryonic cells from non hematopoietic tissues |
CN102550542A (zh) * | 2011-08-09 | 2012-07-11 | 臻景生物技术(上海)有限公司 | 用于脂肪干细胞的无血清冻存液及脂肪干细胞库的建立 |
Non-Patent Citations (1)
Title |
---|
杨波 等: "肝细胞低温保存的实验研究", 《中国生物医学工程学报》 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105494317A (zh) * | 2016-03-06 | 2016-04-20 | 李倩 | 一种人脂肪干细胞用的细胞冻存液 |
RU2655222C2 (ru) * | 2016-05-05 | 2018-05-24 | Константин Валентинович Котенко | Способ подготовки жировой ткани к криоконсервированию |
CN106719602A (zh) * | 2016-11-30 | 2017-05-31 | 广州赛莱拉干细胞科技股份有限公司 | 一种冻存液及其应用与冻存脂肪组织的方法 |
CN106719600A (zh) * | 2016-11-30 | 2017-05-31 | 广州赛莱拉干细胞科技股份有限公司 | 一种脂肪组织冻存液 |
WO2018214943A1 (zh) * | 2017-05-24 | 2018-11-29 | 西比曼生物科技(上海)有限公司 | 一种冻存细胞制剂及细胞复苏方式 |
CN108552156A (zh) * | 2017-11-13 | 2018-09-21 | 广东艾时代生物科技有限责任公司 | 一种无血清的诱导多功能干细胞冻存液及冻存方法 |
CN108048398A (zh) * | 2017-12-23 | 2018-05-18 | 淮北智淮科技有限公司 | 一种干细胞冻存与复苏方法 |
CN109221089A (zh) * | 2018-10-16 | 2019-01-18 | 浙江美泰生物科技有限公司 | 一种脂肪组织的冻存液及脂肪组织冻存的方法 |
CN109430252A (zh) * | 2018-12-25 | 2019-03-08 | 成都赋智健康科技有限公司 | 一种干细胞冻存液及其制作方法 |
CN109380214A (zh) * | 2018-12-28 | 2019-02-26 | 中国医学科学院整形外科医院 | 一种无血清细胞冻存剂及其制备方法、使用方法,冻存液 |
CN109497043A (zh) * | 2018-12-28 | 2019-03-22 | 中国医学科学院整形外科医院 | 无血清纳米材料冻存剂及其制备方法、使用方法,冻存液 |
CN109566600A (zh) * | 2018-12-29 | 2019-04-05 | 中国医学科学院整形外科医院 | 一种用于脂肪干细胞的冻存前处理方法 |
CN109845728A (zh) * | 2019-03-25 | 2019-06-07 | 西安医斯美生物科技有限公司 | 临床应用级别的脂肪组织冻存液及冻存方法 |
CN109845728B (zh) * | 2019-03-25 | 2021-07-23 | 西安医斯美生物科技有限公司 | 临床应用级别的脂肪组织冻存液及冻存方法 |
CN110839616A (zh) * | 2019-11-29 | 2020-02-28 | 安徽惠恩生物科技股份有限公司 | 一种干细胞的冷冻液及其冷冻方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102907416B (zh) | 2016-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102907416B (zh) | 一种可维持细胞活性的组织冻存液 | |
CN104145943B (zh) | 一种人脐带华通氏胶组织的冻存保护液及其制备与应用 | |
CN108207930B (zh) | 一种鸡尾酒式冷冻保护剂及其应用 | |
CN102550542B (zh) | 用于脂肪干细胞的无血清冻存液及脂肪干细胞库的建立 | |
CN101974484B (zh) | 一种人脐带间充质干细胞的制备方法 | |
CN104026118B (zh) | 一种免疫细胞冻存液、其制备方法及应用 | |
CN106982821A (zh) | 脐带间充质干细胞临床冻存保护液组合物及其用途 | |
CN104918486B (zh) | 冷冻保护试剂,冷冻保护和冷冻保存的组合物,其用途,和冷冻保存方法 | |
CN106465710B (zh) | 脂肪组织冻存液及脂肪组织冻存方法 | |
CN105961374A (zh) | 细胞冻存液 | |
CN106922648A (zh) | 一种间充质干细胞低温保存液及其制备方法 | |
CN104560869B (zh) | 一种制备绒毛膜间充质干细胞的方法 | |
CN103298926A (zh) | 干细胞悬浮液 | |
AU2017339344A1 (en) | A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium | |
EP3219320B1 (en) | Method and solution for cryopreservation of umbilical cord blood and peripheral blood | |
CN108617638A (zh) | 组织和/或细胞冻存保护液及其制备与应用 | |
CN104705291A (zh) | 一种脐血单个核细胞冻存液、应用、制备方法 | |
CN104523753A (zh) | 人脐带间充质干细胞培养上清活性因子及细胞裂解液的制备方法、产品与应用 | |
KR20120117209A (ko) | 줄기세포 동결보존액 및 이를 이용하는 줄기세포 동결보존방법 | |
CN108184818A (zh) | 一种人胎盘间充质干细胞悬液保护剂 | |
CN107006452A (zh) | 一种人脐带间充质干细胞源外泌体冻干保存方法及其应用 | |
CN104222069A (zh) | 红系祖细胞冻存液及其应用 | |
CN106614524B (zh) | 一种间充质干细胞的保存液以及保存方法 | |
CN105211052A (zh) | 一种培养后的nkt细胞的冻存液及其制备方法 | |
CN104472474A (zh) | 一种人脂肪间充质干细胞冻存液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 200233 Guiping Road, Xuhui District, No. 333, building 1, building 5, building Applicant after: CELLULAR BIOMEDICINE GROUP (SHANGHAI) Ltd. Applicant after: CELLULAR BIOMEDICINE GROUP (WUXI) Ltd. Address before: 200233 Guiping Road, Xuhui District, No. 333, building 1, building 5, building Applicant before: Zhenjing Biotechnology (Shanghai) Co.,Ltd. Applicant before: CHINA BIOTECH (WUXI) Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: STEMCELL BIOLOGICAL TECHNOLOGIES (SHANGHAI) CO., LTD. TO: CBM BIOTECHNOLOGY (SHANGHAI) CO., LTD. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180516 Address after: 201210 building 3, Faraday Road, China (Shanghai) free trade pilot area, Pudong New Area, Shanghai, China (3) Co-patentee after: WUXI CELLULAR BIOPHARMACEUTICAL Group Ltd. Patentee after: SHANGHAI CELLULAR BIOPHARMACEUTICAL Group Ltd. Address before: No. 5, building No. 1, No. 333, Guiping Road, Xuhui District, Shanghai Co-patentee before: CELLULAR BIOMEDICINE GROUP (WUXI) Ltd. Patentee before: CELLULAR BIOMEDICINE GROUP (SHANGHAI) Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230821 Address after: 214174 area a, area a and area B on the first floor of building 7, No. 1699, Huishan Avenue, Huishan Economic Development Zone, Wuxi, Jiangsu Patentee after: WUXI CELLULAR BIOPHARMACEUTICAL Group Ltd. Address before: 201210 building 3, Faraday Road, China (Shanghai) free trade pilot area, Pudong New Area, Shanghai, China (3) Patentee before: SHANGHAI CELLULAR BIOPHARMACEUTICAL Group Ltd. Patentee before: WUXI CELLULAR BIOPHARMACEUTICAL Group Ltd. |